BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16319070)

  • 1. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
    Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS
    J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J; Cooper SK; Phang JM
    J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.
    Schultze K; Böck B; Eckert A; Oevermann L; Ramacher D; Wiestler O; Roth W
    Apoptosis; 2006 Sep; 11(9):1503-12. PubMed ID: 16820965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.
    Song JH; Song DK; Pyrzynska B; Petruk KC; Van Meir EG; Hao C
    Brain Pathol; 2003 Oct; 13(4):539-53. PubMed ID: 14655759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
    Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
    Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
    Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD.
    Grund K; Ahmadi R; Jung F; Funke V; Gdynia G; Benner A; Sykora J; Walczak H; Joos S; Felsberg J; Reifenberger G; Wiestler OD; Herold-Mende C; Roth W
    Cancer Biol Ther; 2008 Dec; 7(12):1982-90. PubMed ID: 19158480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
    Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC
    Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
    Kang DW; Choi CH; Park JY; Kang SK; Kim YK
    Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-mediated cleavage of beta-catenin precedes drug-induced apoptosis in resistant cancer cells.
    Senthivinayagam S; Mishra P; Paramasivam SK; Yallapragada S; Chatterjee M; Wong L; Rana A; Rana B
    J Biol Chem; 2009 May; 284(20):13577-13588. PubMed ID: 19289465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y; Yuan T; Yao W; Liao K
    FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion.
    Coras R; Hölsken A; Seufert S; Hauke J; Eyüpoglu IY; Reichel M; Tränkle C; Siebzehnrübl FA; Buslei R; Blümcke I; Hahnen E
    Mol Cancer Ther; 2007 Jun; 6(6):1745-54. PubMed ID: 17541035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M; Lee TW; Yim AP; Mok TS; Chen GG
    J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells.
    Wang LH; Yang XY; Zhang X; Huang J; Hou J; Li J; Xiong H; Mihalic K; Zhu H; Xiao W; Farrar WL
    Immunity; 2004 Feb; 20(2):205-18. PubMed ID: 14975242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazone.
    von Schwarzenberg K; Held SA; Schaub A; Brauer KM; Bringmann A; Brossart P
    Cell Mol Life Sci; 2009 Apr; 66(7):1295-308. PubMed ID: 19252820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
    Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
    Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.